The mission of the Comprehensive Arrhythmia Research & Management Center is to provide worldwide pioneering leadership in advancing research and clinical treatments for cardiac arrhythmias, particularly atrial fibrillation, a disease that causes both short and long term impairment in the quality of life for millions worldwide. The CARMA Center is advancing research to better understand this disease and develop new medical techniques and interventions that greatly improve the lives of patients.
The CARMA Center leverages the outstanding interdisciplinary research environment at the University of Utah to create a multifaceted and comprehensive program to better understand and manage cardiac arrhythmias. CARMA creates novel opportunities for specialists from a wide range of fields, including Cardiology, Imaging, Biomarkers, and Biomedical Engineering, and basic science disciplines to collaborate on investigations that advance the treatment of a disease that has a dramatic impact on societies around the world.
The CARMA Center also fulfills an academic mission by providing an interdisciplinary training program for undergraduate, doctoral, and medical trainees in the School of Medicine, Bioengineering, (Medical) Physics, Radiology, and the School of Computing at the University of Utah and University Hospital. Ultimately, the CARMA Center will have achieved its mission when cardiac arrhythmia disease management teams can accurately diagnosis, treat, and cure the disease, allowing patients to return to healthy, productive lives.
To redefine the diagnosis and management of atrial fibrillation through a unique interdisciplinary program of basic and clinical research focused on the understanding, diagnosis, and clinical treatment of atrial fibrillation.
The CARMA Center works as a uniquely multifaceted and comprehensive program, collaborating with research partners to further develop the technology, research, and clinical management for the advancement of world-class medical treatment of atrial arrhythmias.
Research: The Atrial Fibrillation Program will lead the initiative in overcoming major obstacles of the evaluation and successful treatment and management of atrial fibrillation.
Teaching: Sharing technological creations and discoveries with academic partners, students, residents, fellows, and physicians will improve arrhythmia management techniques.
Partnership: Collaboration with other disciplines is integral to success, combining knowledge and expertise for forward advancement in diagnosis and treatment of atrial fibrillation.